REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Wellnanopharm Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: All Other Food Manufacturing | Pesticide and Other Agricultural Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | Toilet Preparation Manufacturing | General Line Grocery Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Wellnanopharm Sp. z o.o. Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Wellnanopharm Sp. z o.o. is based in Poland, with the head office in Krakow. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The enterprise was incorporated on March 08, 2019. The company’s latest financial report indicates a net sales revenue drop of 81.97% in 2022. Its’ total assets recorded a growth of 238.96%. In 2022, Wellnanopharm Sp. z o.o.’s net profit margin decreased by 22980.48%.

Headquarters
Ul. Jerzego Samuela Bandtkiego 19
Krakow; Malopolskie; Postal Code: 30-129

Contact Details: Purchase the Wellnanopharm Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Wellnanopharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Wellnanopharm Sp. z o.o. report to view the information.
Incorporation Date:
March 08, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Wellnanopharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-81.97%▼
Total operating revenue
-88.34%▼
Operating profit (EBIT)
36.66%▲
Net Profit (Loss) for the Period
41.09%▲
Total assets
238.96%▲
Total equity
-30.75%▼
Operating Profit Margin (ROS)
-23651.22%▼
Net Profit Margin
-22980.48%▼
Return on Equity (ROE)
-49.63%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Sartorius Stedim Poland Sp. z o.o.
 
Polpharma Biologics S.A.
Clinical Research Center Sp. z o.o.
 
Ecomelius Institute Sp. z o.o.
Europea East Sp. z o.o.
 
Agene Sp. z o.o.
Zawamed Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo